Association between matrix metalloproteinase‐9 and worsening heart failure events in patients with chronic heart failure

AIMS: Matrix metalloproteinase (MMP) is up‐regulated during heart failure (HF) and influences ventricular remodeling. We hypothesized that disparity between MMP‐9 and tissue inhibitors of MMP‐1 (TIMP‐1) results in clinical manifestations and is related to prognostic risk in patients with chronic HF....

Descripción completa

Detalles Bibliográficos
Autores principales: Morishita, Tetsuji, Uzui, Hiroyasu, Mitsuke, Yasuhiko, Amaya, Naoki, Kaseno, Kenichi, Ishida, Kentaro, Fukuoka, Yoshitomo, Ikeda, Hiroyuki, Tama, Naoki, Yamazaki, Taketoshi, Lee, Jong‐Dae, Tada, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542740/
https://www.ncbi.nlm.nih.gov/pubmed/28772055
http://dx.doi.org/10.1002/ehf2.12137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542740/
https://www.ncbi.nlm.nih.gov/pubmed/28772055
http://dx.doi.org/10.1002/ehf2.12137

Ejemplares similares